Fibronectin Adsorption on Electrospun Synthetic Vascular Grafts Attracts Endothelial Progenitor Cells and Promotes Endothelialization in Dynamic In Vitro Culture.

Ruben Daum, Dmitri Visser, Constanze Wild, Larysa Kutuzova, Maria Schneider, Günter Lorenz, Martin Weiss, Svenja Hinderer, Ulrich A Stock, Martina Seifert, Katja Schenke-Layland
Author Information
  1. Ruben Daum: NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany. ORCID
  2. Dmitri Visser: NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany.
  3. Constanze Wild: Institute of Medical Immunology and BIH Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany. ORCID
  4. Larysa Kutuzova: Applied Chemistry, University of Reutlingen, 72762 Reutlingen, Germany.
  5. Maria Schneider: Institute of Medical Immunology and BIH Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.
  6. Günter Lorenz: Applied Chemistry, University of Reutlingen, 72762 Reutlingen, Germany.
  7. Martin Weiss: NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany. ORCID
  8. Svenja Hinderer: NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany.
  9. Ulrich A Stock: Department of Cardiothoracic Surgery, Royal Brompton and Harefield Foundation Trust, Harefield Hospital Hill End Rd, Harefiled UB9 6JH, UK.
  10. Martina Seifert: Institute of Medical Immunology and BIH Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany. ORCID
  11. Katja Schenke-Layland: NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany. ORCID

Abstract

Appropriate mechanical properties and fast endothelialization of synthetic grafts are key to ensure long-term functionality of implants. We used a newly developed biostable polyurethane elastomer (TPCU) to engineer electrospun vascular scaffolds with promising mechanical properties (E-modulus: 4.8 ± 0.6 MPa, burst pressure: 3326 ± 78 mmHg), which were biofunctionalized with fibronectin (FN) and decorin (DCN). Neither uncoated nor biofunctionalized TPCU scaffolds induced major adverse immune responses except for minor signs of polymorph nuclear cell activation. The in vivo endothelial progenitor cell homing potential of the biofunctionalized scaffolds was simulated in vitro by attracting endothelial colony-forming cells (ECFCs). Although DCN coating did attract ECFCs in combination with FN (FN + DCN), DCN-coated TPCU scaffolds showed a cell-repellent effect in the absence of FN. In a tissue-engineering approach, the electrospun and biofunctionalized tubular grafts were cultured with primary-isolated vascular endothelial cells in a custom-made bioreactor under dynamic conditions with the aim to engineer an advanced therapy medicinal product. Both FN and FN + DCN functionalization supported the formation of a confluent and functional endothelial layer.

Keywords

References

  1. Sci Rep. 2017 Jun 13;7(1):3375 [PMID: 28611395]
  2. Biomaterials. 2014 Feb;35(7):2130-9 [PMID: 24333025]
  3. Kidney Int. 1993 Feb;43(2):334-45 [PMID: 8441229]
  4. Biomaterials. 2011 Oct;32(30):7469-78 [PMID: 21764120]
  5. PLoS One. 2013 Oct 08;8(10):e77316 [PMID: 24116223]
  6. Matrix Biol. 2015 Apr;43:15-26 [PMID: 25661523]
  7. Curr Opin Hematol. 2016 May;23(3):253-9 [PMID: 27055047]
  8. Urol Res. 2003 Oct;31(5):341-6 [PMID: 14574540]
  9. Cell Tissue Res. 2009 Jan;335(1):17-25 [PMID: 18855014]
  10. Kidney Int Suppl. 1998 Sep;67:S100-8 [PMID: 9736263]
  11. Matrix Biol. 2012 Mar;31(2):101-12 [PMID: 22155154]
  12. J Clin Med. 2019 Feb 04;8(2): [PMID: 30720769]
  13. C R Biol. 2012 Aug;335(8):520-8 [PMID: 22938918]
  14. Stem Cell Reports. 2016 Oct 11;7(4):802-816 [PMID: 27693424]
  15. Acta Biomater. 2017 Apr 15;53:13-28 [PMID: 28119112]
  16. Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21671-6 [PMID: 21106754]
  17. Eur J Cell Biol. 1991 Feb;54(1):10-7 [PMID: 1827765]
  18. J Cell Biol. 1987 Jun;104(6):1683-91 [PMID: 3584245]
  19. Sci Rep. 2017 Dec 5;7(1):17027 [PMID: 29208929]
  20. Adv Healthc Mater. 2015 Nov 18;4(16):2326-41 [PMID: 25778713]
  21. Development. 1993 Jun;118(2):489-98 [PMID: 8223275]
  22. J Biol Chem. 1998 Nov 6;273(45):29979-85 [PMID: 9792718]
  23. Biomaterials. 2011 Mar;32(8):2099-105 [PMID: 21185593]
  24. Biomaterials. 2005 Oct;26(30):5999-6008 [PMID: 15894371]
  25. Invest Ophthalmol Vis Sci. 2012 Dec 17;53(13):8333-43 [PMID: 23150625]
  26. Tissue Eng Part C Methods. 2016 Jul;22(7):663-70 [PMID: 27206552]
  27. Biotechnol Bioeng. 2012 Jul;109(7):1808-16 [PMID: 22359201]
  28. Biomaterials. 2012 Jul;33(21):5259-66 [PMID: 22521489]
  29. Tissue Eng. 2000 Apr;6(2):85-103 [PMID: 10941205]
  30. Int J Biomater. 2012;2012:397813 [PMID: 22481939]
  31. J Funct Biomater. 2019 Jul 09;10(3): [PMID: 31324062]
  32. PLoS One. 2013 Nov 22;8(11):e82456 [PMID: 24278482]
  33. Oncotarget. 2018 Jan 3;9(4):5480-5491 [PMID: 29435195]
  34. Tissue Eng Part A. 2009 Sep;15(9):2643-51 [PMID: 19207042]
  35. Nat Rev Cardiol. 2013 Jul;10(7):410-21 [PMID: 23689702]
  36. Mol Biol Cell. 2008 Mar;19(3):994-1006 [PMID: 18094043]
  37. Biochem J. 1991 Dec 1;280 ( Pt 2):411-4 [PMID: 1747115]
  38. Front Bioeng Biotechnol. 2019 Apr 03;7:68 [PMID: 31001528]
  39. Matrix Biol. 1996 Sep;15(4):239-50 [PMID: 8892224]
  40. J Invasive Cardiol. 2010 Oct;22(10):481-7 [PMID: 20944188]
  41. Biomaterials. 2009 Mar;30(8):1542-50 [PMID: 19111338]
  42. Ann Thorac Surg. 2005 Nov;80(5):1794-801 [PMID: 16242457]
  43. Endothelium. 2006 Nov-Dec;13(6):385-401 [PMID: 17169771]
  44. J Saudi Heart Assoc. 2013 Oct;25(4):247-54 [PMID: 24198449]
  45. Tissue Eng Part C Methods. 2008 Jun;14(2):97-105 [PMID: 18544026]
  46. Langmuir. 2010 Jun 1;26(11):8147-54 [PMID: 20131757]
  47. Circulation. 2001 Sep 18;104(12 Suppl 1):I108-14 [PMID: 11568040]
  48. J Cell Sci. 2001 Aug;114(Pt 16):2989-3000 [PMID: 11686302]
  49. Colloids Surf B Biointerfaces. 2011 Jun 15;85(1):32-9 [PMID: 21123036]
  50. Stem Cells Int. 2016;2016:1406304 [PMID: 27413378]
  51. Sci Adv. 2016 Aug 26;2(8):e1600188 [PMID: 27574702]
  52. Nat Commun. 2017 Feb 09;8:14361 [PMID: 28181491]
  53. Cell Tissue Res. 2012 Jan;347(1):177-86 [PMID: 21866313]
  54. Nat Methods. 2012 Jun 28;9(7):676-82 [PMID: 22743772]
  55. FASEB J. 2012 Dec;26(12):4925-36 [PMID: 22919069]
  56. Eur J Vasc Endovasc Surg. 2000 Jul;20(1):21-4 [PMID: 10906292]
  57. J Invest Dermatol. 1982 Jul;79 Suppl 1:51s-59s [PMID: 7045245]
  58. Biores Open Access. 2014 Jun 1;3(3):117-26 [PMID: 24940563]
  59. Tissue Eng Part A. 2009 May;15(5):1081-9 [PMID: 18831688]
  60. Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2191-8 [PMID: 24876354]
  61. Cell Adh Migr. 2009 Jan-Mar;3(1):3-6 [PMID: 19372733]
  62. J Mater Sci Mater Med. 2008 Jul;19(7):2595-603 [PMID: 18197370]
  63. Blood. 2012 Feb 16;119(7):1683-92 [PMID: 22117039]
  64. J Cell Physiol. 2001 Apr;187(1):37-47 [PMID: 11241347]
  65. Biomaterials. 2014 Jul;35(22):5700-10 [PMID: 24746961]
  66. J Biol Chem. 2008 Jun 20;283(25):17406-15 [PMID: 18413316]
  67. J Cell Biol. 2009 May 18;185(4):743-54 [PMID: 19433454]
  68. Am J Cardiol. 1993 Mar 15;71(8):754-7 [PMID: 8447279]
  69. Am J Pathol. 2012 Aug;181(2):380-7 [PMID: 22735579]
  70. Cytometry. 1997 Jan 1;27(1):71-6 [PMID: 9000587]
  71. J Mech Behav Biomed Mater. 2014 Jun;34:253-63 [PMID: 24631624]
  72. Front Biosci (Schol Ed). 2010 Jan 01;2:239-55 [PMID: 20036944]
  73. J Cell Mol Med. 2007 Sep-Oct;11(5):1149-61 [PMID: 17979890]
  74. J Biol Chem. 1981 Aug 10;256(15):8050-7 [PMID: 7263639]
  75. J Vasc Surg. 2004 Mar;39(3):655-60 [PMID: 14981463]
  76. Matrix Biol. 2014 Apr;35:103-11 [PMID: 24447998]
  77. J Biomed Mater Res A. 2009 Jun 15;89(4):865-75 [PMID: 18465817]
  78. Am J Pathol. 1994 May;144(5):962-74 [PMID: 8178945]
  79. Acta Biomater. 2010 Jan;6(1):110-22 [PMID: 19540370]
  80. Acta Biomater. 2005 Sep;1(5):575-82 [PMID: 16701837]
  81. Biochemistry. 2005 Nov 15;44(45):15064-73 [PMID: 16274253]
  82. FASEB J. 1998 Jan;12(1):47-56 [PMID: 9438410]
  83. Am J Pathol. 2001 Feb;158(2):673-80 [PMID: 11159204]
  84. FASEB J. 2009 May;23(5):1447-58 [PMID: 19136616]
  85. Semin Vasc Surg. 1997 Mar;10(1):3-7 [PMID: 9068070]
  86. Microvasc Res. 2001 Jul;62(1):26-42 [PMID: 11421658]
  87. J Cell Biochem. 1984;26(2):107-16 [PMID: 6084665]
  88. Cardiovasc Res. 2015 Dec 1;108(3):377-86 [PMID: 26084310]
  89. Sci Rep. 2019 Mar 5;9(1):3446 [PMID: 30837604]
  90. J Cell Biol. 1987 Dec;105(6 Pt 1):2559-68 [PMID: 3693393]
  91. J Tissue Eng Regen Med. 2015 Aug;9(8):861-88 [PMID: 23365048]
  92. EBioMedicine. 2015 Mar 28;2(5):406-20 [PMID: 26137585]
  93. J Biol Chem. 2013 Jan 4;288(1):598-607 [PMID: 23155052]
  94. Tissue Eng Part B Rev. 2013 Aug;19(4):292-307 [PMID: 23252992]
  95. Front Biosci. 2004 May 01;9:1422-32 [PMID: 14977557]
  96. Biomaterials. 2011 Aug;32(22):5046-55 [PMID: 21546078]
  97. Mol Cancer Res. 2008 May;6(5):785-94 [PMID: 18505923]
  98. Biomaterials. 2006 Mar;27(8):1470-8 [PMID: 16168475]
  99. Blood. 2004 Jun 1;103(11):4164-72 [PMID: 14976058]
  100. Org Biomol Chem. 2005 Aug 21;3(16):2899-906 [PMID: 16186917]
  101. J Biol Chem. 1998 Oct 23;273(43):28116-21 [PMID: 9774430]
  102. Acta Biomater. 2013 Feb;9(2):4948-55 [PMID: 23099303]
  103. Stem Cells. 2017 Apr;35(4):909-919 [PMID: 28248004]
  104. Am J Pathol. 2003 Sep;163(3):869-78 [PMID: 12937128]
  105. Biointerphases. 2015 Mar 30;10(1):019002 [PMID: 25708632]
  106. J Cell Mol Med. 2012 Sep;16(9):2117-26 [PMID: 22225866]
  107. Circ Res. 2006 Oct 13;99(8):853-60 [PMID: 17008606]
  108. J Clin Invest. 2011 Jul;121(7):2668-78 [PMID: 21633168]
  109. Nanomedicine (Lond). 2008 Feb;3(1):45-60 [PMID: 18393666]
  110. J Tissue Eng Regen Med. 2018 Nov;12(11):2164-2178 [PMID: 30079631]
  111. Cell Adh Migr. 2010 Jul-Sep;4(3):377-81 [PMID: 20421733]
  112. Int Wound J. 2015 Jun;12(3):313-6 [PMID: 23742140]
  113. Vascular. 2009 May-Jun;17 Suppl 1:S45-54 [PMID: 19426609]
  114. Tissue Eng Part C Methods. 2019 Aug;25(8):500-511 [PMID: 31337288]
  115. Nat Clin Pract Cardiovasc Med. 2007 Jul;4(7):389-95 [PMID: 17589429]
  116. Dev Dyn. 2018 Mar;247(3):492-508 [PMID: 28891150]
  117. Mol Endocrinol. 2011 Aug;25(8):1431-43 [PMID: 21659473]
  118. Acta Biomater. 2012 Mar;8(3):1330-8 [PMID: 21964214]
  119. Sci Rep. 2018 Jan 8;8(1):110 [PMID: 29311692]
  120. Cytotechnology. 2016 May;68(3):355-69 [PMID: 26091616]
  121. Appl Sci (Basel). 2019 Apr;9(7): [PMID: 31890320]
  122. Adv Exp Med Biol. 2018;1097:1-27 [PMID: 30315537]
  123. J Vet Med Sci. 2004 Jun;66(6):695-700 [PMID: 15240945]

MeSH Term

Adsorption
Bioreactors
Blood Vessel Prosthesis
Cells, Cultured
Decorin
Endothelial Progenitor Cells
Fibronectins
Humans
Immunity
Male
Tissue Engineering
Tissue Scaffolds

Chemicals

Decorin
Fibronectins

Word Cloud

Created with Highcharts 10.0.0FNendothelialscaffoldsbiofunctionalizedDCNTPCUvascularcellsmechanicalpropertiesendothelializationgraftsbiostablepolyurethaneengineerelectrospun±fibronectindecorincellprogenitorECFCs+bioreactorAppropriatefastsynthetickeyensurelong-termfunctionalityimplantsusednewlydevelopedelastomerpromisingE-modulus:4806MPaburstpressure:332678mmHgNeitheruncoatedinducedmajoradverseimmuneresponsesexceptminorsignspolymorphnuclearactivationvivohomingpotentialsimulatedvitroattractingcolony-formingAlthoughcoatingattractcombinationDCN-coatedshowedcell-repellenteffectabsencetissue-engineeringapproachtubularculturedprimary-isolatedcustom-madedynamicconditionsaimadvancedtherapymedicinalproductfunctionalizationsupportedformationconfluentfunctionallayerFibronectinAdsorptionElectrospunSyntheticVascularGraftsAttractsEndothelialProgenitorCellsPromotesEndothelializationDynamicVitroCultureelectrospinningtissueengineeringgraft

Similar Articles

Cited By